Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine
Condition: Chikungunya Interventions: Biological: Inactivated Chikungunya virus vaccine 20 mcg; Biological: Inactivated Chikungunya virus vaccine 30 mcg; Biological: Inactivated Chikungunya virus vaccine 10 mcg; Biological: Placebo Sponsor: Bharat Biotech International Limited Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials